Rohit Farmer, Ph.D.Clinical Trials: How They Work, How Patients Are Recruited, and Whether Participants Are Paid
pub2post😀😀AI/ML Study Trends (2010-2023)
📈 Rapid growth: 3106 studies; 62.8% from 2021-2023
🧑🔬 Only 7.6% FDA-regulated
🏥 Predominantly hospital/clinic sponsors
🌍 75.3% from high-income countries
Tr😀ends in AI/ML studies (2010-2023)
🧠 Only 7.6% FDA-regulated
🧪 56.2% randomized, 58.9% prospective
🏥 44.2% hospital/clinic-sponsored
🌍 75.3% from high-income countries
https://tnyp.me/jG1jMhnS/m #AI #MachineLearning #ClinicalTrials #ResearchGrowth
The New York Times - Breaking News, US News, World News and Videos [Unofficial]GLP-1 Drugs: 6 Things We’ve Learned About Their Effects
https://fed.brid.gy/r/https://www.nytimes.com/2026/06/08/well/glp1-drugs-weight-loss.html
Genelife Clinical ResearchThis article explains what international regulatory acceptability actually requires — and what to look for in a CRO partner that can deliver it.
#Nutraceuticals #ClinicalTrials #India #CRO #FDA #EMA #InternationalResearch #DietarySupplements
https://genelifecr.blogspot.com/2026/06/conducting-nutraceutical-clinical.html
Psychotherapy Commission ACPEThis article describes a pilot trial in which psilocybin is combined with structured cognitive behavioral therapy to treat major depressive disorder, showing safety, high engagement, and notable symptom reduction including remission for several participants. The approach emphasizes a standardized therapeutic framework to accompany psychedelic sessions and examines potential cognitive mechanisms like emotional regulation and positive self-schemas.
The piece is of interest to psychology-focused readers because it highlights how structured psychotherapeutic methods can interact with psychedelic-assisted treatment to influence mood, cognition, and behavior, and it discusses potential mechanisms and the importance of treatment manuals for replication and broader application.
Article Title: Psychedelic therapy standardized for clinical depression shows massive promise in pilot trial
Link to PsyPost Article: https://nolinkpreview.com/www.psypost.org/psychedelic-therapy-standardized-for-clinical-depression-shows-massive-promise-i/
#psychology #psychedelictherapy #majordepressivedisorder #cbt #emotionregulation #positiveemotion #remission #clinicaltrials #mentalhealthresearch #treatmentmanuals
KillBait NewsNew targeted cancer drugs show promising results but chemotherapy remains essential for now
📰 Original title: Smart cancer drugs could replace chemotherap
🤖 IA: It's clickbait ⚠️
👥 Users: It's clickbait ⚠️
New targeted cancer drugs show promising results but chemotherapy remains essential for now
New research presented at the American Society of Clinical Oncology (ASCO) conference in Chicago highlights significant progress in cancer treatment through precision-targeted drugs and personalized therapies. One of the most discussed developments was an experimental drug, GRWD5769, designed to help the immune system recognize and attack cancer cells. When combined with immunotherapy, it achieved tumor reductions of at least 30 percent across multiple cancer types, with 26 out of 83 patients showing meaningful improvement. Another promising advancement involves Darasxnorasib, a daily pill for pancreatic cancer patients. In clinical trials involving 500 individuals, the drug nearly doubled average survival time compared to standard chemotherapy, increasing it from approximately 6.6 months to 13.2 months. Researchers described this as a major step forward for a disease known for its poor prognosis. The OPTIMA trial, led by University College London, demonstrated how genetic testing can identify breast cancer patients who may safely avoid chemotherapy. Among 4,000 participants, low-risk individuals were successfully treated with hormone therapy alone. Similarly, new treatment combinations for bladder cancer are helping patients avoid invasive surgery. Despite these encouraging results, experts warn that cancer rates are expected to rise significantly, from 165 cases per 100,000 people in 2025 to 200 by 2050. Annual diagnoses could increase from 20 million to over 35 million globally due to aging populations and demographic changes. Additional studies also highlighted lifestyle factors. Chronic insomnia was linked to a higher risk of several cancers among younger adults, while practices such as yoga were shown to improve mental health and reduce fatigue in patients. Overall, while targeted therapies are advancing rapidly, they are not yet a complete replacement for chemotherapy but represent an important shift toward more personalized cancer care.
KillBaitNew targeted cancer drugs show promising results but chemotherapy remains essential for now
📰 Original title: Smart cancer drugs could replace chemotherap
🤖 IA: It's clickbait ⚠️
👥 Users: It's clickbait ⚠️
New targeted cancer drugs show promising results but chemotherapy remains essential for now
New research presented at the American Society of Clinical Oncology (ASCO) conference in Chicago highlights significant progress in cancer treatment through precision-targeted drugs and personalized therapies. One of the most discussed developments was an experimental drug, GRWD5769, designed to help the immune system recognize and attack cancer cells. When combined with immunotherapy, it achieved tumor reductions of at least 30 percent across multiple cancer types, with 26 out of 83 patients showing meaningful improvement. Another promising advancement involves Darasxnorasib, a daily pill for pancreatic cancer patients. In clinical trials involving 500 individuals, the drug nearly doubled average survival time compared to standard chemotherapy, increasing it from approximately 6.6 months to 13.2 months. Researchers described this as a major step forward for a disease known for its poor prognosis. The OPTIMA trial, led by University College London, demonstrated how genetic testing can identify breast cancer patients who may safely avoid chemotherapy. Among 4,000 participants, low-risk individuals were successfully treated with hormone therapy alone. Similarly, new treatment combinations for bladder cancer are helping patients avoid invasive surgery. Despite these encouraging results, experts warn that cancer rates are expected to rise significantly, from 165 cases per 100,000 people in 2025 to 200 by 2050. Annual diagnoses could increase from 20 million to over 35 million globally due to aging populations and demographic changes. Additional studies also highlighted lifestyle factors. Chronic insomnia was linked to a higher risk of several cancers among younger adults, while practices such as yoga were shown to improve mental health and reduce fatigue in patients. Overall, while targeted therapies are advancing rapidly, they are not yet a complete replacement for chemotherapy but represent an important shift toward more personalized cancer care.
Africa: Africa's Precision Medicine Future Depends On Stronger Research and Clinical Trial Systems: [Nigeria Health Watch] Precision medicine will not deliver equity for Africa if Africa remains underrepresented in the evidence that shapes it. The endorsement of a new resolution on Precision Medicine at the 79th World Health Assembly reflects an important step towards health equity… http://newsfeed.facilit8.network/TStcB4 #PrecisionMedicine #HealthEquity #UniversalHealthCoverage #ClinicalTrials #AfricaHealth
The global regulatory direction for nutraceuticals is clear: prove it clinically, or lose the claim.
The problem: clinical trials in the US and EU are expensive enough that the ROI is genuinely difficult.
The solution more international nutraceutical companies are finding: conduct the study in India.
#Nutraceuticals #ClinicalTrials #India #CRO #FDA #EMA #DietarySupplements #EvidenceBased
https://genelifecr.blogspot.com/2026/05/the-evidence-gap-in-nutraceuticals-why.html
